| 0 |
Isocitrate Dehydrogenase 1 Inhibitor [EPC] |
1 |
0.0005 |
| 1 |
Nitrogen Binding Agent [EPC] |
1 |
0.0004 |
| 2 |
CD19-directed Chimeric Antigen Receptor [EPC] |
1 |
0.0001 |
| 3 |
CD30-directed Immunoconjugate [EPC] |
1 |
0.0001 |
| 4 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
2 |
0.0001 |
| 5 |
Potassium Binder [EPC] |
1 |
0.0001 |
| 6 |
Programmed Death Ligand-1 Blocker [EPC] |
1 |
0.0000 |
| 7 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
4 |
0.0000 |
| 8 |
Ester Local Anesthetic [EPC] |
1 |
0.0000 |
| 9 |
Non-Standardized Chemical Allergen [EPC] |
1 |
0.0000 |
| 10 |
Amide Local Anesthetic [EPC] |
1 |
0.0000 |
| 11 |
Antiarrhythmic [EPC] |
1 |
0.0000 |
| 12 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 13 |
Alkylating Drug [EPC] |
2 |
0.0000 |
| 14 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 15 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 16 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 17 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 18 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 19 |
beta-Adrenergic Blocker [EPC] |
2 |
0.0000 |
| 20 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 21 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 22 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 23 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 24 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 25 |
Kinase Inhibitor [EPC] |
3 |
0.0000 |
| 26 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 27 |
Proton Pump Inhibitor [EPC] |
3 |
0.0000 |
| 28 |
Insulin Analog [EPC] |
2 |
0.0000 |
| 29 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 30 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 31 |
Corticosteroid [EPC] |
5 |
0.0000 |
| 32 |
Platinum-based Drug [EPC] |
1 |
0.0000 |
| 33 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 35 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 36 |
Vitamin C [EPC] |
1 |
0.0000 |
| 37 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
3 |
0.0000 |
| 38 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 39 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 40 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |